Literature DB >> 23824110

Synthesis of azetidines and pyrrolidines via iodocyclisation of homoallyl amines and exploration of activity in a zebrafish embryo assay.

Antonio Feula1, Sundeep S Dhillon, Rama Byravan, Mandeep Sangha, Ronald Ebanks, Mariwan A Hama Salih, Neil Spencer, Louise Male, Istvan Magyary, Wei-Ping Deng, Ferenc Müller, John S Fossey.   

Abstract

Room temperature iodocyclisation of homoallylamines stereoselectively delivers functionalised 2-(iodomethyl)azetidine derivatives in high yield. Increasing reaction temperature from 20 °C to 50 °C switches the reaction outcome to realise the stereoselective formation of functionalised 3-iodopyrrolidine derivatives. It was shown that these pyrrolidines are formed via thermal isomerisation of the aforementioned azetidines. Primary and secondary amines could be reacted with iodomethyl azetidine derivatives to deliver stable methylamino azetidine derivatives. With subtle changes to the reaction sequences homoallyl amines could be stereoselectively converted to either cis- or trans-substituted 3-amino pyrrolidine derivatives at will. The stereochemical divergent synthesis of cis and trans substituted pyrrolidines supports an ion part, aziridinium, isomerisation pathway for azetidine to pyrrolidine isomerisation. Six azetidine derivatives were probed in a zebrafish embryo developmental assay to detect potential biological effects through the analysis of morphology and motility behaviour phenotypes. The range of effects across the probed molecules demonstrates the suitability of this assay for screening azetidine derivatives. One of the probed molecules, rac-(((cis)-1-benzyl-4-phenylazetidin-2-yl)methyl)piperidine, exhibited particularly interesting effects in the developmental assay presenting with hypopigmentation and reduced circulation amongst others. This shows that the zebrafish embryo provides a fast, sensitive and effective way to screen new compounds and in the future in combination with existing in vivo and in vitro assays it will become an integral part in drug discovery and development.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23824110     DOI: 10.1039/c3ob41007b

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  8 in total

Review 1.  Transition metal-free one-pot synthesis of nitrogen-containing heterocycles.

Authors:  Simpal Kumari; Dharma Kishore; Sarvesh Paliwal; Rajani Chauhan; Jaya Dwivedi; Aakanksha Mishra
Journal:  Mol Divers       Date:  2015-06-09       Impact factor: 2.943

2.  Potential biotechnological capabilities of cultivable mycobiota from carwash effluents.

Authors:  Timothy Sibanda; Ramganesh Selvarajan; Memory Tekere; Hlengilizwe Nyoni; Stephen Meddows-Taylor
Journal:  Microbiologyopen       Date:  2017-07-17       Impact factor: 3.139

3.  Palladium and Platinum 2,4-cis-amino Azetidine and Related Complexes.

Authors:  Akina Yoshizawa; Antonio Feula; Andrew G Leach; Louise Male; John S Fossey
Journal:  Front Chem       Date:  2018-06-21       Impact factor: 5.221

4.  Lewis acidic FeCl3 promoted 2-aza-Cope rearrangement to afford α-substituted homoallylamines in dimethyl carbonate.

Authors:  Karthik Gadde; Jonas Daelemans; Bert U W Maes; Kourosch Abbaspour Tehrani
Journal:  RSC Adv       Date:  2019-06-07       Impact factor: 3.361

5.  Synthesis of optically active 2-substituted azetidine-2-carbonitriles from chiral 1-arylethylamine via α-alkylation of N-borane complexes.

Authors:  Eiji Tayama; Nobuhiro Nakanome
Journal:  RSC Adv       Date:  2021-07-06       Impact factor: 4.036

6.  Synthesis of tertiary alkyl fluorides and chlorides by site-selective nucleophilic ring-opening reaction of α-aryl azetidinium salts.

Authors:  Eiji Tayama; Kohei Kawai
Journal:  RSC Adv       Date:  2021-12-13       Impact factor: 3.361

7.  Rigid and concave, 2,4-cis-substituted azetidine derivatives: A platform for asymmetric catalysis.

Authors:  Akina Yoshizawa; Antonio Feula; Louise Male; Andrew G Leach; John S Fossey
Journal:  Sci Rep       Date:  2018-04-25       Impact factor: 4.379

8.  Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia.

Authors:  Xingjian Li; Daniel T Payne; Badarinath Ampolu; Nicholas Bland; Jane T Brown; Mark J Dutton; Catherine A Fitton; Abigail Gulliver; Lee Hale; Daniel Hamza; Geraint Jones; Rebecca Lane; Andrew G Leach; Louise Male; Elena G Merisor; Michael J Morton; Alex S Quy; Ruth Roberts; Rosanna Scarll; Timothy Schulz-Utermoehl; Tatjana Stankovic; Brett Stevenson; John S Fossey; Angelo Agathanggelou
Journal:  Medchemcomm       Date:  2019-08-01       Impact factor: 3.597

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.